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Position information (x, y, z) in dynamic imaging was collected using IMARIS 9.1.0 and ZEN (blue edition); Images were processed and
quantified using FIJI v1.0.
The squared displacement (SD) analysis was conducted using Mean square displacement analysis of particles trajectories package in
MATLAB R2017a. Plots of initial coordinates against displacement distances were generated using MATLAB R2017a. Box-and-dot plots
were generated using ggplot2 package in R. Wilcoxon rank-sum test was used for statistical comparison between two groups.
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Numbers were determined based on sufficient consistencies between samples and the number of cells needed for position analysis in
dynamic imaging.
No data were excluded.
Biological replicates were used for all experiments. In multiplexed retroviral clonal analysis, slice culture was performed in 14, 12, or 9
replicates at cardiac, posterior vagal, or both regions, respectively; For clonal analysis via photoconversion, we performed single-cell
photoconversion with n = 11 replicates on cardiac neural crest, n = 5 replicates on posterior vagal neural crest cell and n = 2 replicates on all
post-otic migrating cardiac crest cells for stream-specific photoconversion. Immunohistochemistry for premigratory Pax7+ cells was
performed in n=3 embryos.Molecular perturbation was performed with n = 11 replicates for RIA-DN-Fgfr11-YFP, n = 4 replicates for DN-Cxcr4-
YFP or n = 10 replicates for DN-Ret-YFP (8/10 injected with H2B-RFP control). Time-lapse imaging for cardiac, posterior vagal and lateral view
were performed successfully with 2, 1, 2 replicates. Replicate numbers for time-lapse imaging is relatively low since success rate was low due
to tissue drifting during 8-10 hour sessions. To analyze cell trajectories, we tracked n= 21 and n = 18 individual cells for cardiac and posterior
vagal migrating cells.
In molecular perturbation of RET, H2B-RFP virus was used as control in the same embryo. Randomization was achieved by infection events.
Blinding was not relevant to this study. Retroviral lineage analysis is non-invasive approach that label wild-type cells, thus comparison is not
relevant. In molecular perturbation of RET, mutant and control virus infect cells in the same embryo so will be compared in the same context.
Primary antibodies used: 1:500 Mouse anti-smooth muscle actin IgG2a, Sigma-Cat#A2547, clone 1A4 monoclonal; 1:500 Mouse
anti-HuC/D IgG2b, Invitrogen-Cat#A21271, clone 16A11 monoclonal; 1:500 Mouse anti-TuJ1 IgG2a, Biolegend-Cat# 801201,
clone TUJ1 monoclonal; 1:500 Rabbit anti-Tyrosine Hydroxylase (TH), Millipore-Cat# AB152, polyclonal; 1:10 8-IE7 (monoclonal
mouse anti-GFAP IgG1), DSHB, 1:10 3H5 (monoclonal mouse anti-HNK1 IgM), DSHB, 1:10 PAX7 (monoclonal mouse anti-Pax7
IgG1), DSHB, 1:10 IE8 (monoclonal mouse anti-P0 IgG1), DSHB.
Secondary antibodies used: 1:1000 goat anti-mouse IgG2a 633, #A21136 (polyclonal), 1:1000 goat anti-mouse IgG1 647,
#A21240 (polyclonal), 1:1000 goat anti-mouse IgG2b 647, #A21146 (polyclonal), 1:1000 goat anti-mouse IgM 647, #A21238
(polyclonal), 1:1000 donkey anti-rabbit 647, #A31573 (polyclonal). All secondary antibodies from Invitrogen Molecular Probes).
Validations are available on DSHB website for GFAP, HNK1, Pax7, P0 antibodies; Sigma website for Mouse anti-smooth muscle
actin, Invitrogen for mouse antiHuC/D, Biolegend for Mouse anti-TuJ1, Millipor for Rabbit anti-Tyrosine Hydroxylase.
GFAP: species reactivity Mouse, Rat; applications include ELISA, Immunohistochemistry, Western Blot.
HNK1: species reactivity Chicken, Human, Lamprey, Shark; applications include Immunofluorescence, Immunohistochemistry,
Pax7: species reactivity Amphibian, Avian, Bovine, Canine, Fish, Goat, Human, Mouse, Ovine, Porcine, Quail, Rat, Turtle,
Xenopus, Zebrafish; applications include Chromatin Immunoprecipitation, FACS, FFPE, Gel Supershift, Immunofluorescence,
Immunohistochemistry, Immunoprecipitation, Western Blot.
P0: species reactivity Chicken, Planaria, Quail; applications include Immunohistochemistry, Western Blot.
Mouse anti-smooth muscle actin: species reactivity human, frog, sheep, chicken, goat, bovine, rat, guinea pig, mouse, canine,
rabbit, snake; applications include immunohistochemistry, indirect immunofluorescence, western blot.
mouse antiHuC/D: species reactivity for Avian, Chicken, Human, Zebrafish; applications include immunohistochemistry,
immunofluorescence, western blot, ELISA, immunocytochemistry.
Mouse anti-TuJ1: species reactivity Human, Mouse, Rat; verified applications include immunohistochemistry, western blot.
Rabbit anti-Tyrosine Hydroxylase: species reactivity Human, Mouse, Rat, applications include ELISA, immunocytochemistry,

